
View larger version (148K):
[in a new window]
|
Fig. 7. Anti-ORC2 antibody staining and BrdU labeling in follicle cells. All images
were generated using the confocal microscope. Background was intentionally
increased in images F, G, I and L to reveal presence or absence of faint
staining patterns. (A) Wild-type with anti-ORC2. (B) The transgenic line for
BP construct with anti-ORC2. (C) The transgenic line for Yes-3.8S construct
with anti-ORC2. (D,E) The transgenic lines for pCaryos-3.8S construct with
anti-ORC2, lines 1 and 3, respectively. Line 1 amplifies only to very low
level due to genomic position effects, while line 3 amplifies to high level,
as shown in Fig. 8. (F)
k43fs293/k431 with anti-ORC2. (G)
satin with anti-ORC2. (H) chiffon null mutant, genotype
chiffonwf24 /Df(2)RA5, with anti-ORC2. (I)
chiffon null mutant with anti-ORC2 as in H. (J) Wild type with BrdU
labeling. (K) chiffon null mutant, genotype
chiffonwf24 /Df(2)RA5, with BrdU labeling. (L)
chiffon null mutant, genotype chiffonwf24
/Df(2)RA5, with BrdU labeling as in K. The circles indicate the
nuclei.
|